George Zavoico Joins Cantor Fitzgerald’s New York Office

New York, NY – March 27, 2006 – Cantor Fitzgerald & Co., a leading global financial services provider to the institutional equity and fixed-income markets, today announced that George Zavoico, Ph.D., has joined the firm as an Equity Research Analyst covering the life sciences sector. In his new role at Cantor, Dr. Zavoico will publish research on companies involved in biotechnology, pharmaceuticals, medical devices, and diagnostics. [br][br]Prior to joining Cantor Fitzgerald, Dr. Zavoico was a founder and President of Cronamere Consulting Group, L.L.C. (CCG), an independent biotechnology and pharmaceutical industry consulting and medical writing and media company. Dr. Zavoico established CCG in 1997 and specialized in competitive drug research and marketing assessment, medical communications for the industry and general public, due diligence studies for investment banking, and consulting on regulatory affairs issues, including the writing and preparation of clinical trial reports. Prior to CCG, Dr. Zavoico held senior research program positions at Bristol-Myers Squibb, Alexion Pharmaceuticals, and T Cell Sciences. [br][br]“We are excited that George is joining our growing equity research team,” said Phil Marber, President and CEO of Cantor Fitzgerald’s Equity Capital Markets Group. “His broad knowledge of the life sciences sector coupled with his extensive industry experience will play an important role as we continue to expand our business.” [br][br]“Joining Cantor Fitzgerald and its dynamic environment is a great opportunity,” said Dr. Zavoico. “I’m looking forward to helping Cantor grow its equity research group and expand its business further.” [br][br]Dr. Zavoico received a Bachelor of Science in biology from St. Lawrence University (1974), and a doctorate degree in physiology from the University of Virginia (1981). He held post-doctoral positions at the University of Connecticut Health Center and Brigham & Women’s Hospital (Harvard University). [br][br]About Cantor Fitzgerald [br][br]Cantor Fitzgerald, & Co. is a leading financial services provider to the institutional equity and fixed income markets, with wwwucts and services including sales and trading, investment banking, asset management, market data, and market commentary. For nearly 60 years, Cantor Fitzgerald, a proven and resilient leader, has been committed to delivering a unique brand of unparalleled trading and distribution services, wwwuct expertise, innovative technology and customer service to its clients around the world. [br][br]This commitment also extends to numerous philanthropic endeavors, including the firm’s pledge to donate 25% of the profits it would otherwise distribute to its partners through 2006 to benefit the families of the employees lost on September 11, 2001. For more information, please visit aws-dev1.cantor.com. [br][br]Contacts: [br][br]Michael Geller – New York 212-610-2430 [br][br]mgeller@cantor.com [br][br]Adrian Thomas – London 44-207-894-8647 [br][br]athomas@cantor.com


View PDF PDF version